VAERS data released Friday by the Centers for Disease Control and Prevention show 1,295,329 reports of adverse events from all age groups following COVID-19 vaccines, including 28,714 deaths and 236,767 serious injuries between Dec. 14, 2020, and June 3, 2022.
The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,295,329 reports of adverse events following COVID-19 vaccines were submitted between Dec. 14, 2020, and June 3, 2022, to the Vaccine Adverse Event Reporting System (VAERS). That’s an increase of 7,734 adverse events over the previous week.
VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.
The data included a total of 28,714 reports of deaths — an increase of 182 over the previous week — and 236,767 serious injuries, including deaths, during the same time period — up 1,726 compared with the previous week.
Foreign reports are reports foreign subsidiaries send to U.S. vaccine manufacturers. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.
Of the 13,225 U.S. deaths reported as of June 3, 16% occurred within 24 hours of vaccination, 20% occurred within 48 hours of vaccination and 59% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.
In the U.S., 588 million COVID-19 vaccine doses had been administered as of June 3, including 347 million doses of Pfizer, 222 million doses of Moderna and 19 million doses of Johnson & Johnson (J&J).
Every Friday, VAERS publishes vaccine injury reports received as of a specified date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.
Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.
U.S. VAERS data from Dec. 14, 2020, to June 3, 2022, for 6-month-olds to 5-year-olds show:
- 1,658 adverse events, including 63 cases rated as serious and 3 reported deaths.
- 4 reports of myocarditis and pericarditis (heart inflammation).
The CDC uses a narrowed case definition of “myocarditis,” which excludes cases of cardiac arrest, ischemic strokes and deaths due to heart problems that occur before one has the chance to go to the emergency department.
- 13 reports of blood clotting disorders.
U.S. VAERS data from Dec. 14, 2020, to June 3, 2022, for 5- to 11-year-olds show:
- 11,133 adverse events, including 292 rated as serious and 5 reported deaths.
- 22 reports of myocarditis and pericarditis.
The Defender has noticed over previous weeks that reports of myocarditis and pericarditis have been removed by the CDC from the VAERS system in this age group. No explanation was provided.
- 43 reports of blood clotting disorders.
U.S. VAERS data from Dec. 14, 2020, to June 3, 2022, for 12- to 17-year-olds show:
- 32,026 adverse events, including 1,834 rated as serious and 44 reported deaths.
- 62 reports of anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 97% of cases attributed to Pfizer’s vaccine.
- 655 reports of myocarditis and pericarditis with 643 cases attributed to Pfizer’s vaccine.
- 166 reports of blood clotting disorders with all cases attributed to Pfizer. VAERS reported 167 cases of blood clotting disorders in the 12- to 17-year-old age group last week.
U.S. VAERS data from Dec. 14, 2020, to June 3, 2022, for all age groups combined, show:
- 20% of deaths were related to cardiac disorders.
- 53% of those who died were male, 42% were female and the remaining death reports did not include the gender of the deceased.
- The average age of death was 73.
- As of June 3, 5,574 pregnant women reported adverse events related to COVID-19 vaccines, including 1,743 reports of miscarriage or premature birth.
- Of the 3,615 cases of Bell’s Palsy reported, 51% were attributed to Pfizervaccinations, 40% to Moderna and 8% to J&J.
- 884 reports of Guillain-Barré syndrome, with 42% of cases attributed to Pfizer, 30% to Moderna and 28% to J&J.
- 2,290 reports of anaphylaxis where the reaction was life-threatening, required treatment or resulted in death.
- 1,725 reports of myocardial infarction.
- 14,079 reports of blood-clotting disorders in the U.S. Of those, 6,291 reports were attributed to Pfizer, 5,048 reports to Moderna and 2,701 reports to J&J.
- 4,223 cases of myocarditis and pericarditis with 2,589 cases attributed to Pfizer, 1,434 cases to Moderna and 186 cases to J&J.
- 10 cases of Creutzfeldt-Jakob disease with 4 cases attributed Pfizer, 5 cases to Moderna and 1 case to J&J.
U.S. government diverts $10 billion in funding for more COVID vaccines
The money was diverted from plans to buy COVID-19 tests and personal protective equipment, reported NBC, as well as funding for research and development of new COVID-19 vaccines, according to AP.
The redirected funds will be used to start negotiating contracts with vaccine-makers to make new doses for the fall, including “next-generation” vaccines that pharmaceutical companies are developing to target new COVID-19 variants.
Roughly $5 billion will go to support the purchase of new COVID-19 vaccine doses for a fall immunization campaign and $4.9 billion will be used to procure about 10 million remaining courses of Pfizer’s Paxlovid COVID-19 antiviral pill, a White House official who asked not to be named told Bloomberg.
The administration’s move to divert funding to buy more COVID-19 vaccine doses comes just days after the Center for Disease Control (CDC) shared data with NBC News revealing the U.S. wasted 82.1 million COVID-19 vaccines from December 2020 through mid-May 2022.
Studies suggest link between fatal brain disease and COVID vaccines
A French pre-print paper published in May on Creutzfeldt-Jakob Disease(CJD) and COVID-19 vaccination identified a new form of sporadic CJD that occurred within days of receiving a first or second dose of Pfizer or Moderna COVID-19 vaccines.
CJD is a degenerative brain disorder that leads to dementia and, ultimately, death.
Researchers believe the prion region from the original Wuhan COVID-19 variant’s spike protein was incorporated into mRNA vaccines and adenovirus vector vaccines — given to hundreds of millions of humans — and that it can cause a new type of rapidly progressing sporadic CJD.
Researchers analyzed 26 cases of CJD and found the first symptoms appeared on average 11.38 days after injection with a COVID-19 vaccine.
Of the 26 cases, 20 had died by the time the study was published and six were still alive. “The 20 deaths occurred only 4.76 months after the injection. Among them, 8 of them led to a sudden death (2.5 months),” researchers wrote.
Biden administration secures 10 million doses of COVID vaccine for kids under 5
The Biden administration Thursday said it made available 10 million doses of COVID-19 vaccines for children under age 5 to states and healthcare workers with “millions more available in the coming weeks.”
The White House unveiled its “Operational Plan” for vaccinating the youngest age group — one week before advisors to the U.S. Food and Drug Administration (FDA) are scheduled to meet to decide whether to grant Emergency Use Authorization for the Pfizer-BioNTech and Moderna pediatric vaccines for babies as young as 6 months old.
Children under 5 could begin receiving the vaccines as early as “the week of June 20th — with the program ramping up over time as more doses are delivered and more appointments become available,” the White House said.
Children’s Health Defense (CHD) Chairman and Chief Legal Counsel Robert F. Kennedy, Jr. called on parents and physicians “now more than ever” to “step into the breach to protect our babies from our government.”
Kennedy said the COVID-19 countermeasures, including the vaccines, were “never about science or public health,” adding, “Now they have departed from common sense and into naked cruelty and barbarism.”
Severe COVID-19 ‘rare’ in people who didn’t get vaccine
A survey of 300,000 people who didn’t get the COVID-19 vaccine revealed the unvaccinated didn’t place a disproportionate burden on health systems — in fact, they experienced very low rates of hospitalization and severe COVID-19.
The international Control Group project — also known as the Vax Control Group — conducted the survey.
The survey data offer important revelations, including:
- The unvaccinated “control group” participants have experienced very low hospitalization rates and severe COVID-19 disease rates.
- They are more likely to rely on self-care, using natural products such as vitamin D, vitamin C, zinc and quercetin.
- Many have used ivermectin and hydroxychloroquine.
- Women have suffered menstrual and bleeding abnormalities despite being unvaccinated, possibly due to spike protein exposure and shedding.
- Their mental health burden has been considerable, possibly aggravated by stigmatization by the mainstream, “vaccinated” society.
- They have been heavily discriminated against because of their decision to exercise their right to informed consent and refuse the administration of “genetic vaccines.”
Canadian government approves vaccine-injured man’s compensation claim
Ross Wightman, a 40-year-old husband and father of two, said it took years of submitting paperwork before the government approved the claim. Wightman was diagnosed with Guillain-Barré syndrome (GBS), a rare condition affecting the nervous system that left him partially paralyzed, soon after receiving his first and only dose of the AstraZeneca COVID-19 vaccine in April 2021.
Wightman did not divulge the exact amount of the payout. However, he said he did not qualify for the program’s maximum payout of $284,000. He said he plans to appeal the payout amount to the program’s medical review board, which he said failed to take into account all his symptoms.
There have been 46,149 officially recorded adverse reactions to COVID-19 vaccines reported in Canada, but only a handful of claimants have received compensation.
Reporting by Children’s Health Defense.